P3 Health PartnersPIII +4.90%44 5-Year Yield-on-Cost % is 0.00 as of Jul. 13, 2026. GuruFocus rates PIII with a GF Score™ of 44/100 and a GF Value™ of $9.07 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 281 Healthcare Providers & Services companies, P3 Health Partners ranks worse than 355871.53% on this metric.
P3 Health Partners's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for P3 Health Partners's 5-Year Yield-on-Cost % or its related term are showing as below:
PIII's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.92 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
P3 Health Partners (NAS:PIII) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
P3 Health Partners 5-Year Yield-on-Cost % Related Terms
PIII vs EHSI, CDIX, DCGO: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, P3 Health Partners's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's 5-Year Yield-on-Cost % falls into.
P3 Health Partners 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
P3 Health Partners (PIII) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #999999 out of 281 companies in the Healthcare Providers & Services industry.
Is P3 Health Partners' 5-Year Yield-on-Cost % too high?
P3 Health Partners' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, P3 Health Partners ranks #999999 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, P3 Health Partners has a GF Score™ of 44/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' 5-Year Yield-on-Cost % compare to EHSI and CDIX?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #999999 out of 281 companies for 5-Year Yield-on-Cost %. This places P3 Health Partners in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on P3 Health Partners and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.07, compared to a current price of $10.28 — trading 13.3% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. P3 Health Partners' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For P3 Health Partners (PIII), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is P3 Health Partners (PIII) Overvalued in 2026?
Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued.
The current stock price of $10.28 is trading 13.3% above its estimated GF Value™ of $9.07.
GuruFocus considers P3 Health Partners to be Modestly Overvalued.
Key valuation signals for PIII:
5-Year Yield-on-Cost %: 0.00
GF Value™: $9.07 vs. price of $10.28 (13.3% above fair value)
No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
44GF Score
Get the complete analysis for PIII
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIII has been successfully added to your 